cytarabine has been researched along with Nevoxanthoendothelioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bieber, T; Irnich, M; Maintz, L; Reinhard, H; Wenzel, J | 1 |
| Argenyi, Z; Hurst, S; Olerud, J; Tran, DT; Wolgamot, GM | 1 |
| Alla, CA; Arbion, F; Blouin, P; Colombat, P; Donadieu, J; Eitenschenck, L; Emile, JF; Machet, MC; Pagnier, A; Plantaz, D; Yvert, M | 1 |
2 review(s) available for cytarabine and Nevoxanthoendothelioma
| Article | Year |
|---|---|
Successful treatment of systemic juvenile xanthogranulomatosis with cytarabine and 2-chlorodeoxyadenosine: case report and review of the literature.
Topics: Cladribine; Cytarabine; Dermatologic Agents; Drug Therapy, Combination; Humans; Infant; Male; Treatment Outcome; Xanthogranuloma, Juvenile | 2017 |
Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.
Topics: Cladribine; Cytarabine; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Infant; Male; Xanthogranuloma, Juvenile | 2010 |
1 other study(ies) available for cytarabine and Nevoxanthoendothelioma
| Article | Year |
|---|---|
An 'eruptive' variant of juvenile xanthogranuloma associated with langerhans cell histiocytosis.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Clobetasol; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Methotrexate; Prednisone; Vincristine; Xanthogranuloma, Juvenile | 2008 |